drugset / Trial / NCT01102140

The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study

NCT01102140 ↗

Phase 2 Terminated 20 enrolled Jennifer Cowger , MD, MS POM Wonderful LLC · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This blinded, controlled study will examine the impact of pomegranate polyphenol extract (POMx, from Pom Wonderful, LLC), 1000mg on cardiomyopathy in subjects with chronic renal insufficiency.

Timeline

Start
2010-07
Primary completion
2013-05-31
Completion
2013-05-31

Outcome

Outcome not reported

Stopped: “Investigator left University of Michigan”

Drugs

EvaluationDrugModalityDoseRoute
Comparator pomegranate polyphenol extract Unknown 1000 mg Oral